SV

Sujith Velandy

Active Director Director DIN 05315104
DIN 05315104 First appointment Jul 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2012
Shareholding value •••• Premium profile

About Sujith Velandy

Data last updated:

Sujith Velandy is a Director at Tyramed Healthcare Private Limited (since 2012). The company operates in Trading. Tyramed Healthcare Private Limited reported revenue of ₹18.8 Lakh (FY 2025).

DIN 05315104
Primary Designation Director
Industry Trading
First Appointment 25 Jul 2012
Oldest Company Age 14 yrs
Largest company Tyramed Healthcare Private Limited · ₹18.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tyramed Healthcare Private Limited U85190KL2012PTC031738
Director25 Jul 20122012₹18.8 Lakh (FY 2025)Active

Board colleagues of Sujith Velandy

Directorship timeline

Open interactive timeline →
Tyramed Healthcare Private Limited
Premium access

Shareholding and investment profile for Sujith Velandy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujith Velandy

Sujith Velandy currently holds 1 directorship: Tyramed Healthcare Private Limited (Director, since 25 Jul 2012, revenue ₹18.8 Lakh (FY 2025)).

Sujith Velandy was first appointed on 25 Jul 2012 as Director at Tyramed Healthcare Private Limited.

The current boards of Sujith Velandy's companies include Sona Premnad Kutteri Kuniyil House (Tyramed Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available